title: Autologous T cells on the attack against AML.
abstract: In this issue of Blood, Greiner and colleagues describe how peptides derived from the mutated nucleophosmin 1 gene (NPM1(mut)) can elicit in vitro CD4(+) and CD8(+) T-cell responses in patients with acute myeloid leukemia, which can lead to antigen-specific lysis of leukemic blasts.
authors.affiliation: University of Antwerp.
authors.forename: Zwi N
authors.initials: ZN
authors.lastname: Berneman
mesh_terms: D015496:CD4-Positive T-Lymphocytes / Q000276:immunology*; D018414:CD8-Positive T-Lymphocytes / Q000276:immunology*; D006801:Humans; D015470:Leukemia, Myeloid, Acute / Q000276:immunology*; D009687:Nuclear Proteins / Q000235:genetics* / Q000276:immunology*; D000090243:Nucleophosmin
chemical_list: C000716967:NPM1 protein, human; D009687:Nuclear Proteins; D000090243:Nucleophosmin